Skip to main content
JS Link, Inc. logo

JS Link, Inc. — Investor Relations & Filings

Ticker · 127120 ISIN · KR7127120004 KO Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2019-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 127120

About JS Link, Inc.

https://en.jslink.co.kr/

JS Link, Inc. is a company with dual operations in biotechnology and advanced materials manufacturing. Formerly known as DNA Link, Inc., its biotechnology division is a genome-based research and development firm. It specializes in genomic mass analysis technology, providing sequencing and analysis services for DNA, RNA, and other genomic data to advance personalized medicine. The company also operates a division dedicated to the manufacturing of high-performance sintered permanent magnets, which are produced using rare earth materials.

Recent filings

Filing Released Lang Actions
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'DNA Link, Inc.' (주식회사 디엔에이링크) for the period of January 1, 2019, to March 31, 2019. It contains detailed financial information, company overview, business operations, and management discussions, which are characteristic of a comprehensive quarterly financial report. It is not an announcement or a summary, but the full report itself. Q1 2019
2019-05-15 Korean
전환가액의조정(제8회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (DNAlink) detailing the adjustment of the conversion price for convertible bonds (8th series). This type of disclosure, which involves changes to the capital structure and conversion terms of debt instruments, falls under the category of capital and financing updates.
2019-05-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares/convertible bonds by A One Asset Management in the company DNA Link. This falls under the category of Major Shareholding Notification (MRQ) as it reports a change in significant share ownership levels.
2019-04-15 Korean
전환가액의조정(제8회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (8th series) issued by DNA Link. It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This type of disclosure regarding capital structure and debt-to-equity conversion terms falls under 'Capital/Financing Update'.
2019-04-11 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, director compensation, etc.) from the meeting held on March 29, 2019. This fits the definition of a Declaration of Voting Results (DVA).
2019-03-29 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 19th fiscal year (2018), which is the standard Korean regulatory filing equivalent to an Annual Report (10-K). It contains comprehensive company information, financial statements, management discussion, and business details for the full fiscal year. It is not an announcement or a summary, but the full report itself. FY 2018
2019-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.